Back to Journals » Patient Preference and Adherence » Volume 13

Cognition and drug adherence to oral hypoglycemic and antihypertensive agents in older adults [Corrigendum]

Authors Bakouni H, Gentil L, Vasiliadis HM

Received 10 July 2019

Accepted for publication 10 July 2019

Published 7 August 2019 Volume 2019:13 Pages 1337—1338


Bakouni H, Gentil L, Vasiliadis HM. Patient Prefer Adherence. 2019;13:891–899.
Following a review of the paper post-publication, the authors found that for the hypertension only and hypertension and diabetes mellitus groups, the estimates presented were for the absolute change and not the percentage change in Mini-Mental State Examination (MMSE) scores. This correction has no impact on the conclusions of the study. The authors had carried out analyses for both absolute and percentage change in MMSE scores. The authors apologize for this error.
In the Results section of the abstract, it should have read: “In participants with hypertension only, the change in MMSE scores was associated with adherence to antihypertensives (β 3.66; 95% CI: 0.14–7.19). In participants with comorbid hypertension and diabetes mellitus type II, the change in MMSE scores was associated with adherence to both antihypertensive and oral hypoglycemic agents (β 2.78; 95% CI: 0.10–5.46).”
In the Results section of the main paper, on page 896, in the second paragraph it should have read: “In the sample with hypertension, the change in cognitive status was positively associated with adherence to antihypertensive agents taken in the year prior to baseline interview (β 3.66; 95% CI: 0.14–7.19).”
In the Results section of the main paper, on page 896, in the third paragraph it should have read: “In the sample including participants diagnosed with both hypertension and diabetes mellitus type II, the change in MMSE scores was positively associated with adherence to both antihypertensive and oral hypoglycemic agents in the year following the baseline interview (β 2.78; 95% CI: 0.10–5.46).”
Read the original article

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]